Australia markets closed
  • ALL ORDS

    6,788.70
    -132.70 (-1.92%)
     
  • ASX 200

    6,574.70
    -125.50 (-1.87%)
     
  • AUD/USD

    0.6533
    -0.0112 (-1.69%)
     
  • OIL

    79.43
    -4.06 (-4.86%)
     
  • GOLD

    1,651.70
    -29.40 (-1.75%)
     
  • BTC-AUD

    29,175.58
    +405.24 (+1.41%)
     
  • CMC Crypto 200

    434.61
    -9.92 (-2.23%)
     
  • AUD/EUR

    0.6737
    -0.0013 (-0.19%)
     
  • AUD/NZD

    1.1363
    -0.0000 (-0.00%)
     
  • NZX 50

    11,434.82
    -83.50 (-0.72%)
     
  • NASDAQ

    11,311.24
    -190.40 (-1.66%)
     
  • FTSE

    7,018.60
    -140.92 (-1.97%)
     
  • Dow Jones

    29,590.41
    -486.27 (-1.62%)
     
  • DAX

    12,284.19
    -247.44 (-1.97%)
     
  • Hang Seng

    17,933.27
    -214.68 (-1.18%)
     
  • NIKKEI 225

    27,153.83
    -159.30 (-0.58%)
     

Fulgent Genetics, Inc. (FLGT) Q2 2022 Earnings Call Transcript

·33-min read
Fulgent Genetics, Inc. (FLGT) Q2 2022 Earnings Call Transcript

On the call today are Ming Hsieh, chief executive officer; Paul Kim, chief financial officer; Dr. Larry Weiss, chief medical officer; Brandon Perthuis, chief commercial officer. The company's press release discussing its financial results is available in the investor relations section of the company's website, fulgentgenetics.com.